<DOC>
	<DOCNO>NCT02396537</DOCNO>
	<brief_summary>The purpose study establish whether premedication topical lidocaine would reduce pain associate IN midazolam administration child . The study design double-blinded , randomize , placebo-controlled trial perform urban , academic pediatric emergency department .</brief_summary>
	<brief_title>Efficacy Topical Lidocaine Decrease Discomfort With Intranasal Midazolam Administration</brief_title>
	<detailed_description>This double-blinded , randomize , placebo-controlled trial perform urban , academic pediatric emergency department annual census 67,000 patient . Children 6-12 year old IN midazolam order eligible enrollment . Patients randomly assign identical intranasal medication ( 4 % Lidocaine 0.9 % saline ) . Patients administer study drug follow IN midazolam . Patients assign pain score midazolam administration use Wong-Baker FACES Pain Rating scale . The primary endpoint pain score analyze two-tailed Mann-Whitney U test , P &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Ages 612 Previously healthy Attending physician concludes patient would benefit administration anxiolysis medication prior minor procedure Moderate severe asthma chronic lung disease Comorbid condition include cerebral palsy , developmental delay , chronic illness deem Attending physician unsafe receive anxiolysis Versed . Any child presenting lifethreatening condition .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Children</keyword>
	<keyword>Midazolam</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Intranasal</keyword>
</DOC>